Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

CYPA and CD147 expression analysis in human glioblastoma: Evidence for a correlation with reduced survival

Matthews, V., Candy, P.A., West, K.A.ORCID: 0000-0002-7036-5334, Knuckey, N.W., Robbins, P., Jeffcote, T. and Boulos, S. (2018) CYPA and CD147 expression analysis in human glioblastoma: Evidence for a correlation with reduced survival. Journal of Translational Science, 4 (5). pp. 1-7.

[img]
Preview
PDF - Published Version
Download (2MB) | Preview
Free to read: https://doi.org/10.15761/JTS.1000249
*No subscription required

Abstract

Glioblastomas (GBMs) are fatal WHO grade IV astrocytomas with a median survival of 14.6 months. Immunohistochemical (IHC) studies indicate that cyclophilin A (CYPA), and its receptor CD147 are elevated in GBM, but the impacts on disease progression are poorly understood. We determined their occurrence in diffuse astrocytomas (WHO grades II-IV) using IHC and evaluated how gene expression affects patient outcomes in The Cancer Genome Atlas (TCGA) and REMBRANDT datasets (GBM and Low-Grade-Glioma: LGG). While IHC staining of CYPA was evident across all tumour grades, CD147 staining increased with tumour grade. However, while analysis of the TCGA grade II/III tumour dataset showed a trend towards high CD147 gene expression and reduced patient survival (HR=2.34, p=0.064, n=132), the results were not statistically significant. By contrast, analysis of the TCGA GBM dataset showed that high CYPA expression was significantly associated with reduced survival (HR=1.30, p=0.009; n=593). Furthermore, Kaplan-Meier analysis of both the TCGA and REMBRANDT (p=0.052; n=176) GBM datasets showed a comparable reduction in survival of about 3-months for patients with high CYPA expression. We found that CYPA gene amplification (≥2.2 copies) occurred in 72% of patients (REMBRANDT GBM dataset) and was correlated with reduced survival (log-rank p = 0.022). Finally, we observed a correlation between CYPA and CD147 gene expression in grade II/III (R=0.481, p=1.81x10-6) and grade IV (R=0.132; p=0.0012) tumours. Together, our data identify CYPA and CD147 as potential pathogenic determinants in glioblastoma.

Item Type: Journal Article
Publisher: OA Text
Copyright: ©2018 Matthews V.
URI: http://researchrepository.murdoch.edu.au/id/eprint/55723
Item Control Page Item Control Page

Downloads

Downloads per month over past year